Global Psoriatic Arthritis (PsA) Treatment Market Growth (Status and Outlook) 2025-2031
According to this study, the global Psoriatic Arthritis (PsA) Treatment market size will reach US$ 18620 million by 2031.
Psoriatic arthritis (PsA) is a chronic, inflammatory disease of the joints and entheses, where tendons and ligaments connect to bone. Like psoriasis, PsA is associated with related health conditions (comorbidities).
It can start at any age and may affect children. The disease often appears between ages 30 and 50. For many people, it starts about 10 years after psoriasis develops, but some develop PsA first or without ever developing or noticing psoriasis.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Psoriatic Arthritis (PsA) Treatment Industry Forecast” looks at past sales and reviews total world Psoriatic Arthritis (PsA) Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Psoriatic Arthritis (PsA) Treatment sales for 2025 through 2031. With Psoriatic Arthritis (PsA) Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Psoriatic Arthritis (PsA) Treatment industry.
This Insight Report provides a comprehensive analysis of the global Psoriatic Arthritis (PsA) Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Psoriatic Arthritis (PsA) Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Psoriatic Arthritis (PsA) Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Psoriatic Arthritis (PsA) Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Psoriatic Arthritis (PsA) Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Psoriatic Arthritis (PsA) Treatment market by product type, application, key players and key regions and countries.
Segmentation by Type:
Psoriatic arthritis (PsA) is a chronic, inflammatory disease of the joints and entheses, where tendons and ligaments connect to bone. Like psoriasis, PsA is associated with related health conditions (comorbidities).
It can start at any age and may affect children. The disease often appears between ages 30 and 50. For many people, it starts about 10 years after psoriasis develops, but some develop PsA first or without ever developing or noticing psoriasis.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Psoriatic Arthritis (PsA) Treatment Industry Forecast” looks at past sales and reviews total world Psoriatic Arthritis (PsA) Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Psoriatic Arthritis (PsA) Treatment sales for 2025 through 2031. With Psoriatic Arthritis (PsA) Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Psoriatic Arthritis (PsA) Treatment industry.
This Insight Report provides a comprehensive analysis of the global Psoriatic Arthritis (PsA) Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Psoriatic Arthritis (PsA) Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Psoriatic Arthritis (PsA) Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Psoriatic Arthritis (PsA) Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Psoriatic Arthritis (PsA) Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Psoriatic Arthritis (PsA) Treatment market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Nonsteriodal Anti-inflammatory Drugs
- Disease Modifying Antirheumatic Drugs
- Biologics
- Hospitals
- Clinics
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Johnson & Johnson
- AbbVie
- Novartis
- UCB
- Roche
- Bristol-Myers Squibb
- Eli Lilly
- Amgen
- AstraZeneca
- Celgene
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Psoriatic Arthritis (PsA) Treatment Market Size (2020-2031)
2.1.2 Psoriatic Arthritis (PsA) Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Psoriatic Arthritis (PsA) Treatment by Country/Region (2020, 2024 & 2031)
2.2 Psoriatic Arthritis (PsA) Treatment Segment by Type
2.2.1 Nonsteriodal Anti-inflammatory Drugs
2.2.2 Disease Modifying Antirheumatic Drugs
2.2.3 Biologics
2.3 Psoriatic Arthritis (PsA) Treatment Market Size by Type
2.3.1 Psoriatic Arthritis (PsA) Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Type (2020-2025)
2.4 Psoriatic Arthritis (PsA) Treatment Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Psoriatic Arthritis (PsA) Treatment Market Size by Application
2.5.1 Psoriatic Arthritis (PsA) Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Application (2020-2025)
3 PSORIATIC ARTHRITIS (PSA) TREATMENT MARKET SIZE BY PLAYER
3.1 Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Player
3.1.1 Global Psoriatic Arthritis (PsA) Treatment Revenue by Player (2020-2025)
3.1.2 Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Player (2020-2025)
3.2 Global Psoriatic Arthritis (PsA) Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PSORIATIC ARTHRITIS (PSA) TREATMENT BY REGION
4.1 Psoriatic Arthritis (PsA) Treatment Market Size by Region (2020-2025)
4.2 Global Psoriatic Arthritis (PsA) Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Psoriatic Arthritis (PsA) Treatment Market Size Growth (2020-2025)
4.4 APAC Psoriatic Arthritis (PsA) Treatment Market Size Growth (2020-2025)
4.5 Europe Psoriatic Arthritis (PsA) Treatment Market Size Growth (2020-2025)
4.6 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Psoriatic Arthritis (PsA) Treatment Market Size by Country (2020-2025)
5.2 Americas Psoriatic Arthritis (PsA) Treatment Market Size by Type (2020-2025)
5.3 Americas Psoriatic Arthritis (PsA) Treatment Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Psoriatic Arthritis (PsA) Treatment Market Size by Region (2020-2025)
6.2 APAC Psoriatic Arthritis (PsA) Treatment Market Size by Type (2020-2025)
6.3 APAC Psoriatic Arthritis (PsA) Treatment Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Country (2020-2025)
7.2 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Type (2020-2025)
7.3 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Psoriatic Arthritis (PsA) Treatment by Region (2020-2025)
8.2 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Type (2020-2025)
8.3 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PSORIATIC ARTHRITIS (PSA) TREATMENT MARKET FORECAST
10.1 Global Psoriatic Arthritis (PsA) Treatment Forecast by Region (2026-2031)
10.1.1 Global Psoriatic Arthritis (PsA) Treatment Forecast by Region (2026-2031)
10.1.2 Americas Psoriatic Arthritis (PsA) Treatment Forecast
10.1.3 APAC Psoriatic Arthritis (PsA) Treatment Forecast
10.1.4 Europe Psoriatic Arthritis (PsA) Treatment Forecast
10.1.5 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Forecast
10.2 Americas Psoriatic Arthritis (PsA) Treatment Forecast by Country (2026-2031)
10.2.1 United States Market Psoriatic Arthritis (PsA) Treatment Forecast
10.2.2 Canada Market Psoriatic Arthritis (PsA) Treatment Forecast
10.2.3 Mexico Market Psoriatic Arthritis (PsA) Treatment Forecast
10.2.4 Brazil Market Psoriatic Arthritis (PsA) Treatment Forecast
10.3 APAC Psoriatic Arthritis (PsA) Treatment Forecast by Region (2026-2031)
10.3.1 China Psoriatic Arthritis (PsA) Treatment Market Forecast
10.3.2 Japan Market Psoriatic Arthritis (PsA) Treatment Forecast
10.3.3 Korea Market Psoriatic Arthritis (PsA) Treatment Forecast
10.3.4 Southeast Asia Market Psoriatic Arthritis (PsA) Treatment Forecast
10.3.5 India Market Psoriatic Arthritis (PsA) Treatment Forecast
10.3.6 Australia Market Psoriatic Arthritis (PsA) Treatment Forecast
10.4 Europe Psoriatic Arthritis (PsA) Treatment Forecast by Country (2026-2031)
10.4.1 Germany Market Psoriatic Arthritis (PsA) Treatment Forecast
10.4.2 France Market Psoriatic Arthritis (PsA) Treatment Forecast
10.4.3 UK Market Psoriatic Arthritis (PsA) Treatment Forecast
10.4.4 Italy Market Psoriatic Arthritis (PsA) Treatment Forecast
10.4.5 Russia Market Psoriatic Arthritis (PsA) Treatment Forecast
10.5 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Forecast by Region (2026-2031)
10.5.1 Egypt Market Psoriatic Arthritis (PsA) Treatment Forecast
10.5.2 South Africa Market Psoriatic Arthritis (PsA) Treatment Forecast
10.5.3 Israel Market Psoriatic Arthritis (PsA) Treatment Forecast
10.5.4 Turkey Market Psoriatic Arthritis (PsA) Treatment Forecast
10.6 Global Psoriatic Arthritis (PsA) Treatment Forecast by Type (2026-2031)
10.7 Global Psoriatic Arthritis (PsA) Treatment Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Psoriatic Arthritis (PsA) Treatment Forecast
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Psoriatic Arthritis (PsA) Treatment Product Offered
11.1.3 Pfizer Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Information
11.2.2 Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Product Offered
11.2.3 Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Johnson & Johnson Main Business Overview
11.2.5 Johnson & Johnson Latest Developments
11.3 AbbVie
11.3.1 AbbVie Company Information
11.3.2 AbbVie Psoriatic Arthritis (PsA) Treatment Product Offered
11.3.3 AbbVie Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 AbbVie Main Business Overview
11.3.5 AbbVie Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Psoriatic Arthritis (PsA) Treatment Product Offered
11.4.3 Novartis Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 UCB
11.5.1 UCB Company Information
11.5.2 UCB Psoriatic Arthritis (PsA) Treatment Product Offered
11.5.3 UCB Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 UCB Main Business Overview
11.5.5 UCB Latest Developments
11.6 Roche
11.6.1 Roche Company Information
11.6.2 Roche Psoriatic Arthritis (PsA) Treatment Product Offered
11.6.3 Roche Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Roche Main Business Overview
11.6.5 Roche Latest Developments
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Information
11.7.2 Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Product Offered
11.7.3 Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Bristol-Myers Squibb Main Business Overview
11.7.5 Bristol-Myers Squibb Latest Developments
11.8 Eli Lilly
11.8.1 Eli Lilly Company Information
11.8.2 Eli Lilly Psoriatic Arthritis (PsA) Treatment Product Offered
11.8.3 Eli Lilly Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Eli Lilly Main Business Overview
11.8.5 Eli Lilly Latest Developments
11.9 Amgen
11.9.1 Amgen Company Information
11.9.2 Amgen Psoriatic Arthritis (PsA) Treatment Product Offered
11.9.3 Amgen Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Amgen Main Business Overview
11.9.5 Amgen Latest Developments
11.10 AstraZeneca
11.10.1 AstraZeneca Company Information
11.10.2 AstraZeneca Psoriatic Arthritis (PsA) Treatment Product Offered
11.10.3 AstraZeneca Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 AstraZeneca Main Business Overview
11.10.5 AstraZeneca Latest Developments
11.11 Celgene
11.11.1 Celgene Company Information
11.11.2 Celgene Psoriatic Arthritis (PsA) Treatment Product Offered
11.11.3 Celgene Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Celgene Main Business Overview
11.11.5 Celgene Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Psoriatic Arthritis (PsA) Treatment Market Size (2020-2031)
2.1.2 Psoriatic Arthritis (PsA) Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Psoriatic Arthritis (PsA) Treatment by Country/Region (2020, 2024 & 2031)
2.2 Psoriatic Arthritis (PsA) Treatment Segment by Type
2.2.1 Nonsteriodal Anti-inflammatory Drugs
2.2.2 Disease Modifying Antirheumatic Drugs
2.2.3 Biologics
2.3 Psoriatic Arthritis (PsA) Treatment Market Size by Type
2.3.1 Psoriatic Arthritis (PsA) Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Type (2020-2025)
2.4 Psoriatic Arthritis (PsA) Treatment Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Psoriatic Arthritis (PsA) Treatment Market Size by Application
2.5.1 Psoriatic Arthritis (PsA) Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Application (2020-2025)
3 PSORIATIC ARTHRITIS (PSA) TREATMENT MARKET SIZE BY PLAYER
3.1 Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Player
3.1.1 Global Psoriatic Arthritis (PsA) Treatment Revenue by Player (2020-2025)
3.1.2 Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Player (2020-2025)
3.2 Global Psoriatic Arthritis (PsA) Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PSORIATIC ARTHRITIS (PSA) TREATMENT BY REGION
4.1 Psoriatic Arthritis (PsA) Treatment Market Size by Region (2020-2025)
4.2 Global Psoriatic Arthritis (PsA) Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Psoriatic Arthritis (PsA) Treatment Market Size Growth (2020-2025)
4.4 APAC Psoriatic Arthritis (PsA) Treatment Market Size Growth (2020-2025)
4.5 Europe Psoriatic Arthritis (PsA) Treatment Market Size Growth (2020-2025)
4.6 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Psoriatic Arthritis (PsA) Treatment Market Size by Country (2020-2025)
5.2 Americas Psoriatic Arthritis (PsA) Treatment Market Size by Type (2020-2025)
5.3 Americas Psoriatic Arthritis (PsA) Treatment Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Psoriatic Arthritis (PsA) Treatment Market Size by Region (2020-2025)
6.2 APAC Psoriatic Arthritis (PsA) Treatment Market Size by Type (2020-2025)
6.3 APAC Psoriatic Arthritis (PsA) Treatment Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Country (2020-2025)
7.2 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Type (2020-2025)
7.3 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Psoriatic Arthritis (PsA) Treatment by Region (2020-2025)
8.2 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Type (2020-2025)
8.3 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PSORIATIC ARTHRITIS (PSA) TREATMENT MARKET FORECAST
10.1 Global Psoriatic Arthritis (PsA) Treatment Forecast by Region (2026-2031)
10.1.1 Global Psoriatic Arthritis (PsA) Treatment Forecast by Region (2026-2031)
10.1.2 Americas Psoriatic Arthritis (PsA) Treatment Forecast
10.1.3 APAC Psoriatic Arthritis (PsA) Treatment Forecast
10.1.4 Europe Psoriatic Arthritis (PsA) Treatment Forecast
10.1.5 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Forecast
10.2 Americas Psoriatic Arthritis (PsA) Treatment Forecast by Country (2026-2031)
10.2.1 United States Market Psoriatic Arthritis (PsA) Treatment Forecast
10.2.2 Canada Market Psoriatic Arthritis (PsA) Treatment Forecast
10.2.3 Mexico Market Psoriatic Arthritis (PsA) Treatment Forecast
10.2.4 Brazil Market Psoriatic Arthritis (PsA) Treatment Forecast
10.3 APAC Psoriatic Arthritis (PsA) Treatment Forecast by Region (2026-2031)
10.3.1 China Psoriatic Arthritis (PsA) Treatment Market Forecast
10.3.2 Japan Market Psoriatic Arthritis (PsA) Treatment Forecast
10.3.3 Korea Market Psoriatic Arthritis (PsA) Treatment Forecast
10.3.4 Southeast Asia Market Psoriatic Arthritis (PsA) Treatment Forecast
10.3.5 India Market Psoriatic Arthritis (PsA) Treatment Forecast
10.3.6 Australia Market Psoriatic Arthritis (PsA) Treatment Forecast
10.4 Europe Psoriatic Arthritis (PsA) Treatment Forecast by Country (2026-2031)
10.4.1 Germany Market Psoriatic Arthritis (PsA) Treatment Forecast
10.4.2 France Market Psoriatic Arthritis (PsA) Treatment Forecast
10.4.3 UK Market Psoriatic Arthritis (PsA) Treatment Forecast
10.4.4 Italy Market Psoriatic Arthritis (PsA) Treatment Forecast
10.4.5 Russia Market Psoriatic Arthritis (PsA) Treatment Forecast
10.5 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Forecast by Region (2026-2031)
10.5.1 Egypt Market Psoriatic Arthritis (PsA) Treatment Forecast
10.5.2 South Africa Market Psoriatic Arthritis (PsA) Treatment Forecast
10.5.3 Israel Market Psoriatic Arthritis (PsA) Treatment Forecast
10.5.4 Turkey Market Psoriatic Arthritis (PsA) Treatment Forecast
10.6 Global Psoriatic Arthritis (PsA) Treatment Forecast by Type (2026-2031)
10.7 Global Psoriatic Arthritis (PsA) Treatment Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Psoriatic Arthritis (PsA) Treatment Forecast
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Psoriatic Arthritis (PsA) Treatment Product Offered
11.1.3 Pfizer Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Information
11.2.2 Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Product Offered
11.2.3 Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Johnson & Johnson Main Business Overview
11.2.5 Johnson & Johnson Latest Developments
11.3 AbbVie
11.3.1 AbbVie Company Information
11.3.2 AbbVie Psoriatic Arthritis (PsA) Treatment Product Offered
11.3.3 AbbVie Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 AbbVie Main Business Overview
11.3.5 AbbVie Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Psoriatic Arthritis (PsA) Treatment Product Offered
11.4.3 Novartis Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 UCB
11.5.1 UCB Company Information
11.5.2 UCB Psoriatic Arthritis (PsA) Treatment Product Offered
11.5.3 UCB Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 UCB Main Business Overview
11.5.5 UCB Latest Developments
11.6 Roche
11.6.1 Roche Company Information
11.6.2 Roche Psoriatic Arthritis (PsA) Treatment Product Offered
11.6.3 Roche Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Roche Main Business Overview
11.6.5 Roche Latest Developments
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Information
11.7.2 Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Product Offered
11.7.3 Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Bristol-Myers Squibb Main Business Overview
11.7.5 Bristol-Myers Squibb Latest Developments
11.8 Eli Lilly
11.8.1 Eli Lilly Company Information
11.8.2 Eli Lilly Psoriatic Arthritis (PsA) Treatment Product Offered
11.8.3 Eli Lilly Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Eli Lilly Main Business Overview
11.8.5 Eli Lilly Latest Developments
11.9 Amgen
11.9.1 Amgen Company Information
11.9.2 Amgen Psoriatic Arthritis (PsA) Treatment Product Offered
11.9.3 Amgen Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Amgen Main Business Overview
11.9.5 Amgen Latest Developments
11.10 AstraZeneca
11.10.1 AstraZeneca Company Information
11.10.2 AstraZeneca Psoriatic Arthritis (PsA) Treatment Product Offered
11.10.3 AstraZeneca Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 AstraZeneca Main Business Overview
11.10.5 AstraZeneca Latest Developments
11.11 Celgene
11.11.1 Celgene Company Information
11.11.2 Celgene Psoriatic Arthritis (PsA) Treatment Product Offered
11.11.3 Celgene Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Celgene Main Business Overview
11.11.5 Celgene Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Psoriatic Arthritis (PsA) Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Psoriatic Arthritis (PsA) Treatment Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Nonsteriodal Anti-inflammatory Drugs
Table 4. Major Players of Disease Modifying Antirheumatic Drugs
Table 5. Major Players of Biologics
Table 6. Psoriatic Arthritis (PsA) Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Psoriatic Arthritis (PsA) Treatment Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Type (2020-2025)
Table 9. Psoriatic Arthritis (PsA) Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Psoriatic Arthritis (PsA) Treatment Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Application (2020-2025)
Table 12. Global Psoriatic Arthritis (PsA) Treatment Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Player (2020-2025)
Table 14. Psoriatic Arthritis (PsA) Treatment Key Players Head office and Products Offered
Table 15. Psoriatic Arthritis (PsA) Treatment Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Psoriatic Arthritis (PsA) Treatment Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Region (2020-2025)
Table 20. Global Psoriatic Arthritis (PsA) Treatment Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Psoriatic Arthritis (PsA) Treatment Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Country (2020-2025)
Table 24. Americas Psoriatic Arthritis (PsA) Treatment Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Type (2020-2025)
Table 26. Americas Psoriatic Arthritis (PsA) Treatment Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Application (2020-2025)
Table 28. APAC Psoriatic Arthritis (PsA) Treatment Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Region (2020-2025)
Table 30. APAC Psoriatic Arthritis (PsA) Treatment Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Psoriatic Arthritis (PsA) Treatment Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Psoriatic Arthritis (PsA) Treatment Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Country (2020-2025)
Table 34. Europe Psoriatic Arthritis (PsA) Treatment Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Psoriatic Arthritis (PsA) Treatment Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Psoriatic Arthritis (PsA) Treatment
Table 40. Key Market Challenges & Risks of Psoriatic Arthritis (PsA) Treatment
Table 41. Key Industry Trends of Psoriatic Arthritis (PsA) Treatment
Table 42. Global Psoriatic Arthritis (PsA) Treatment Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Psoriatic Arthritis (PsA) Treatment Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Psoriatic Arthritis (PsA) Treatment Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Pfizer Details, Company Type, Psoriatic Arthritis (PsA) Treatment Area Served and Its Competitors
Table 47. Pfizer Psoriatic Arthritis (PsA) Treatment Product Offered
Table 48. Pfizer Psoriatic Arthritis (PsA) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Pfizer Main Business
Table 50. Pfizer Latest Developments
Table 51. Johnson & Johnson Details, Company Type, Psoriatic Arthritis (PsA) Treatment Area Served and Its Competitors
Table 52. Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Product Offered
Table 53. Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Johnson & Johnson Main Business
Table 55. Johnson & Johnson Latest Developments
Table 56. AbbVie Details, Company Type, Psoriatic Arthritis (PsA) Treatment Area Served and Its Competitors
Table 57. AbbVie Psoriatic Arthritis (PsA) Treatment Product Offered
Table 58. AbbVie Psoriatic Arthritis (PsA) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. AbbVie Main Business
Table 60. AbbVie Latest Developments
Table 61. Novartis Details, Company Type, Psoriatic Arthritis (PsA) Treatment Area Served and Its Competitors
Table 62. Novartis Psoriatic Arthritis (PsA) Treatment Product Offered
Table 63. Novartis Psoriatic Arthritis (PsA) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Novartis Main Business
Table 65. Novartis Latest Developments
Table 66. UCB Details, Company Type, Psoriatic Arthritis (PsA) Treatment Area Served and Its Competitors
Table 67. UCB Psoriatic Arthritis (PsA) Treatment Product Offered
Table 68. UCB Psoriatic Arthritis (PsA) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. UCB Main Business
Table 70. UCB Latest Developments
Table 71. Roche Details, Company Type, Psoriatic Arthritis (PsA) Treatment Area Served and Its Competitors
Table 72. Roche Psoriatic Arthritis (PsA) Treatment Product Offered
Table 73. Roche Psoriatic Arthritis (PsA) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Roche Main Business
Table 75. Roche Latest Developments
Table 76. Bristol-Myers Squibb Details, Company Type, Psoriatic Arthritis (PsA) Treatment Area Served and Its Competitors
Table 77. Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Product Offered
Table 78. Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Bristol-Myers Squibb Main Business
Table 80. Bristol-Myers Squibb Latest Developments
Table 81. Eli Lilly Details, Company Type, Psoriatic Arthritis (PsA) Treatment Area Served and Its Competitors
Table 82. Eli Lilly Psoriatic Arthritis (PsA) Treatment Product Offered
Table 83. Eli Lilly Psoriatic Arthritis (PsA) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Eli Lilly Main Business
Table 85. Eli Lilly Latest Developments
Table 86. Amgen Details, Company Type, Psoriatic Arthritis (PsA) Treatment Area Served and Its Competitors
Table 87. Amgen Psoriatic Arthritis (PsA) Treatment Product Offered
Table 88. Amgen Psoriatic Arthritis (PsA) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Amgen Main Business
Table 90. Amgen Latest Developments
Table 91. AstraZeneca Details, Company Type, Psoriatic Arthritis (PsA) Treatment Area Served and Its Competitors
Table 92. AstraZeneca Psoriatic Arthritis (PsA) Treatment Product Offered
Table 93. AstraZeneca Psoriatic Arthritis (PsA) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. AstraZeneca Main Business
Table 95. AstraZeneca Latest Developments
Table 96. Celgene Details, Company Type, Psoriatic Arthritis (PsA) Treatment Area Served and Its Competitors
Table 97. Celgene Psoriatic Arthritis (PsA) Treatment Product Offered
Table 98. Celgene Psoriatic Arthritis (PsA) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Celgene Main Business
Table 100. Celgene Latest Developments
Table 1. Psoriatic Arthritis (PsA) Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Psoriatic Arthritis (PsA) Treatment Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Nonsteriodal Anti-inflammatory Drugs
Table 4. Major Players of Disease Modifying Antirheumatic Drugs
Table 5. Major Players of Biologics
Table 6. Psoriatic Arthritis (PsA) Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Psoriatic Arthritis (PsA) Treatment Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Type (2020-2025)
Table 9. Psoriatic Arthritis (PsA) Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Psoriatic Arthritis (PsA) Treatment Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Application (2020-2025)
Table 12. Global Psoriatic Arthritis (PsA) Treatment Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Player (2020-2025)
Table 14. Psoriatic Arthritis (PsA) Treatment Key Players Head office and Products Offered
Table 15. Psoriatic Arthritis (PsA) Treatment Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Psoriatic Arthritis (PsA) Treatment Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Region (2020-2025)
Table 20. Global Psoriatic Arthritis (PsA) Treatment Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Psoriatic Arthritis (PsA) Treatment Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Country (2020-2025)
Table 24. Americas Psoriatic Arthritis (PsA) Treatment Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Type (2020-2025)
Table 26. Americas Psoriatic Arthritis (PsA) Treatment Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Application (2020-2025)
Table 28. APAC Psoriatic Arthritis (PsA) Treatment Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Region (2020-2025)
Table 30. APAC Psoriatic Arthritis (PsA) Treatment Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Psoriatic Arthritis (PsA) Treatment Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Psoriatic Arthritis (PsA) Treatment Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Country (2020-2025)
Table 34. Europe Psoriatic Arthritis (PsA) Treatment Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Psoriatic Arthritis (PsA) Treatment Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Psoriatic Arthritis (PsA) Treatment
Table 40. Key Market Challenges & Risks of Psoriatic Arthritis (PsA) Treatment
Table 41. Key Industry Trends of Psoriatic Arthritis (PsA) Treatment
Table 42. Global Psoriatic Arthritis (PsA) Treatment Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Psoriatic Arthritis (PsA) Treatment Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Psoriatic Arthritis (PsA) Treatment Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Pfizer Details, Company Type, Psoriatic Arthritis (PsA) Treatment Area Served and Its Competitors
Table 47. Pfizer Psoriatic Arthritis (PsA) Treatment Product Offered
Table 48. Pfizer Psoriatic Arthritis (PsA) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Pfizer Main Business
Table 50. Pfizer Latest Developments
Table 51. Johnson & Johnson Details, Company Type, Psoriatic Arthritis (PsA) Treatment Area Served and Its Competitors
Table 52. Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Product Offered
Table 53. Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Johnson & Johnson Main Business
Table 55. Johnson & Johnson Latest Developments
Table 56. AbbVie Details, Company Type, Psoriatic Arthritis (PsA) Treatment Area Served and Its Competitors
Table 57. AbbVie Psoriatic Arthritis (PsA) Treatment Product Offered
Table 58. AbbVie Psoriatic Arthritis (PsA) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. AbbVie Main Business
Table 60. AbbVie Latest Developments
Table 61. Novartis Details, Company Type, Psoriatic Arthritis (PsA) Treatment Area Served and Its Competitors
Table 62. Novartis Psoriatic Arthritis (PsA) Treatment Product Offered
Table 63. Novartis Psoriatic Arthritis (PsA) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Novartis Main Business
Table 65. Novartis Latest Developments
Table 66. UCB Details, Company Type, Psoriatic Arthritis (PsA) Treatment Area Served and Its Competitors
Table 67. UCB Psoriatic Arthritis (PsA) Treatment Product Offered
Table 68. UCB Psoriatic Arthritis (PsA) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. UCB Main Business
Table 70. UCB Latest Developments
Table 71. Roche Details, Company Type, Psoriatic Arthritis (PsA) Treatment Area Served and Its Competitors
Table 72. Roche Psoriatic Arthritis (PsA) Treatment Product Offered
Table 73. Roche Psoriatic Arthritis (PsA) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Roche Main Business
Table 75. Roche Latest Developments
Table 76. Bristol-Myers Squibb Details, Company Type, Psoriatic Arthritis (PsA) Treatment Area Served and Its Competitors
Table 77. Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Product Offered
Table 78. Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Bristol-Myers Squibb Main Business
Table 80. Bristol-Myers Squibb Latest Developments
Table 81. Eli Lilly Details, Company Type, Psoriatic Arthritis (PsA) Treatment Area Served and Its Competitors
Table 82. Eli Lilly Psoriatic Arthritis (PsA) Treatment Product Offered
Table 83. Eli Lilly Psoriatic Arthritis (PsA) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Eli Lilly Main Business
Table 85. Eli Lilly Latest Developments
Table 86. Amgen Details, Company Type, Psoriatic Arthritis (PsA) Treatment Area Served and Its Competitors
Table 87. Amgen Psoriatic Arthritis (PsA) Treatment Product Offered
Table 88. Amgen Psoriatic Arthritis (PsA) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Amgen Main Business
Table 90. Amgen Latest Developments
Table 91. AstraZeneca Details, Company Type, Psoriatic Arthritis (PsA) Treatment Area Served and Its Competitors
Table 92. AstraZeneca Psoriatic Arthritis (PsA) Treatment Product Offered
Table 93. AstraZeneca Psoriatic Arthritis (PsA) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. AstraZeneca Main Business
Table 95. AstraZeneca Latest Developments
Table 96. Celgene Details, Company Type, Psoriatic Arthritis (PsA) Treatment Area Served and Its Competitors
Table 97. Celgene Psoriatic Arthritis (PsA) Treatment Product Offered
Table 98. Celgene Psoriatic Arthritis (PsA) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Celgene Main Business
Table 100. Celgene Latest Developments
LIST OF FIGURES
Figure 1. Psoriatic Arthritis (PsA) Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Psoriatic Arthritis (PsA) Treatment Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Psoriatic Arthritis (PsA) Treatment Sales Market Share by Country/Region (2024)
Figure 8. Psoriatic Arthritis (PsA) Treatment Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Type in 2024
Figure 10. Psoriatic Arthritis (PsA) Treatment in Hospitals
Figure 11. Global Psoriatic Arthritis (PsA) Treatment Market: Hospitals (2020-2025) & ($ millions)
Figure 12. Psoriatic Arthritis (PsA) Treatment in Clinics
Figure 13. Global Psoriatic Arthritis (PsA) Treatment Market: Clinics (2020-2025) & ($ millions)
Figure 14. Psoriatic Arthritis (PsA) Treatment in Others
Figure 15. Global Psoriatic Arthritis (PsA) Treatment Market: Others (2020-2025) & ($ millions)
Figure 16. Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Application in 2024
Figure 17. Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Player in 2024
Figure 18. Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Region (2020-2025)
Figure 19. Americas Psoriatic Arthritis (PsA) Treatment Market Size 2020-2025 ($ millions)
Figure 20. APAC Psoriatic Arthritis (PsA) Treatment Market Size 2020-2025 ($ millions)
Figure 21. Europe Psoriatic Arthritis (PsA) Treatment Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size 2020-2025 ($ millions)
Figure 23. Americas Psoriatic Arthritis (PsA) Treatment Value Market Share by Country in 2024
Figure 24. United States Psoriatic Arthritis (PsA) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Psoriatic Arthritis (PsA) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Psoriatic Arthritis (PsA) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Psoriatic Arthritis (PsA) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Region in 2024
Figure 29. APAC Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Type (2020-2025)
Figure 30. APAC Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Application (2020-2025)
Figure 31. China Psoriatic Arthritis (PsA) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Psoriatic Arthritis (PsA) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Psoriatic Arthritis (PsA) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Psoriatic Arthritis (PsA) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 35. India Psoriatic Arthritis (PsA) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Psoriatic Arthritis (PsA) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Country in 2024
Figure 38. Europe Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Type (2020-2025)
Figure 39. Europe Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Application (2020-2025)
Figure 40. Germany Psoriatic Arthritis (PsA) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 41. France Psoriatic Arthritis (PsA) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Psoriatic Arthritis (PsA) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Psoriatic Arthritis (PsA) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Psoriatic Arthritis (PsA) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Psoriatic Arthritis (PsA) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Psoriatic Arthritis (PsA) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Psoriatic Arthritis (PsA) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Psoriatic Arthritis (PsA) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Psoriatic Arthritis (PsA) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 54. APAC Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 55. Europe Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 57. United States Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 58. Canada Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 59. Mexico Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 60. Brazil Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 61. China Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 62. Japan Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 63. Korea Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 65. India Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 66. Australia Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 67. Germany Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 68. France Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 69. UK Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 70. Italy Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 71. Russia Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 72. Egypt Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 73. South Africa Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 74. Israel Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 75. Turkey Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 76. Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 1. Psoriatic Arthritis (PsA) Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Psoriatic Arthritis (PsA) Treatment Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Psoriatic Arthritis (PsA) Treatment Sales Market Share by Country/Region (2024)
Figure 8. Psoriatic Arthritis (PsA) Treatment Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Type in 2024
Figure 10. Psoriatic Arthritis (PsA) Treatment in Hospitals
Figure 11. Global Psoriatic Arthritis (PsA) Treatment Market: Hospitals (2020-2025) & ($ millions)
Figure 12. Psoriatic Arthritis (PsA) Treatment in Clinics
Figure 13. Global Psoriatic Arthritis (PsA) Treatment Market: Clinics (2020-2025) & ($ millions)
Figure 14. Psoriatic Arthritis (PsA) Treatment in Others
Figure 15. Global Psoriatic Arthritis (PsA) Treatment Market: Others (2020-2025) & ($ millions)
Figure 16. Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Application in 2024
Figure 17. Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Player in 2024
Figure 18. Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Region (2020-2025)
Figure 19. Americas Psoriatic Arthritis (PsA) Treatment Market Size 2020-2025 ($ millions)
Figure 20. APAC Psoriatic Arthritis (PsA) Treatment Market Size 2020-2025 ($ millions)
Figure 21. Europe Psoriatic Arthritis (PsA) Treatment Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size 2020-2025 ($ millions)
Figure 23. Americas Psoriatic Arthritis (PsA) Treatment Value Market Share by Country in 2024
Figure 24. United States Psoriatic Arthritis (PsA) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Psoriatic Arthritis (PsA) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Psoriatic Arthritis (PsA) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Psoriatic Arthritis (PsA) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Region in 2024
Figure 29. APAC Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Type (2020-2025)
Figure 30. APAC Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Application (2020-2025)
Figure 31. China Psoriatic Arthritis (PsA) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Psoriatic Arthritis (PsA) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Psoriatic Arthritis (PsA) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Psoriatic Arthritis (PsA) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 35. India Psoriatic Arthritis (PsA) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Psoriatic Arthritis (PsA) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Country in 2024
Figure 38. Europe Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Type (2020-2025)
Figure 39. Europe Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Application (2020-2025)
Figure 40. Germany Psoriatic Arthritis (PsA) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 41. France Psoriatic Arthritis (PsA) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Psoriatic Arthritis (PsA) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Psoriatic Arthritis (PsA) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Psoriatic Arthritis (PsA) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Psoriatic Arthritis (PsA) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Psoriatic Arthritis (PsA) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Psoriatic Arthritis (PsA) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Psoriatic Arthritis (PsA) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Psoriatic Arthritis (PsA) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 54. APAC Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 55. Europe Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 57. United States Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 58. Canada Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 59. Mexico Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 60. Brazil Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 61. China Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 62. Japan Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 63. Korea Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 65. India Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 66. Australia Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 67. Germany Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 68. France Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 69. UK Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 70. Italy Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 71. Russia Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 72. Egypt Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 73. South Africa Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 74. Israel Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 75. Turkey Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
Figure 76. Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Psoriatic Arthritis (PsA) Treatment Market Size 2026-2031 ($ millions)
